
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18575484
[patent_doc_number] => 11731998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Method of preparing ferric carboxymaltose
[patent_app_type] => utility
[patent_app_number] => 17/579818
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5620
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579818 | Method of preparing ferric carboxymaltose | Jan 19, 2022 | Issued |
Array
(
[id] => 19001973
[patent_doc_number] => 20240066044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING NAD+ METABOLOME IN HEALTHY MIDDLE-AGED POPULATION
[patent_app_type] => utility
[patent_app_number] => 18/261576
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261576
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261576 | METHODS AND COMPOSITIONS FOR INCREASING NAD+ METABOLOME IN HEALTHY MIDDLE-AGED POPULATION | Jan 13, 2022 | Pending |
Array
(
[id] => 20241018
[patent_doc_number] => 12421327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Hydrogels for cell therapy
[patent_app_type] => utility
[patent_app_number] => 17/573517
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16312
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573517 | Hydrogels for cell therapy | Jan 10, 2022 | Issued |
Array
(
[id] => 18978802
[patent_doc_number] => 11903956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Compositions and products for infectious or inflammatory diseases or conditions
[patent_app_type] => utility
[patent_app_number] => 17/572021
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20279
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572021 | Compositions and products for infectious or inflammatory diseases or conditions | Jan 9, 2022 | Issued |
Array
(
[id] => 18559838
[patent_doc_number] => 11725073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Compositions and methods for liquid phase oligonucleotide synthesis
[patent_app_type] => utility
[patent_app_number] => 17/562714
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9384
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562714 | Compositions and methods for liquid phase oligonucleotide synthesis | Dec 26, 2021 | Issued |
Array
(
[id] => 20974828
[patent_doc_number] => 12735509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-15
[patent_title] => Method for producing starch composition
[patent_app_type] => utility
[patent_app_number] => 18/256658
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10936
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256658 | METHOD FOR PRODUCING STARCH COMPOSITION | Dec 15, 2021 | Pending |
Array
(
[id] => 19410616
[patent_doc_number] => 12076409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Polymer-drug conjugates for combination anticancer therapy
[patent_app_type] => utility
[patent_app_number] => 17/546480
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 31
[patent_no_of_words] => 13177
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546480 | Polymer-drug conjugates for combination anticancer therapy | Dec 8, 2021 | Issued |
Array
(
[id] => 19309924
[patent_doc_number] => 12035718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Biofilm penetrating compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/457186
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 14248
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457186
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457186 | Biofilm penetrating compositions and methods | Nov 30, 2021 | Issued |
Array
(
[id] => 18315092
[patent_doc_number] => 11629161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, L-proline and water
[patent_app_type] => utility
[patent_app_number] => 17/537612
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3110
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/537612 | Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, L-proline and water | Nov 29, 2021 | Issued |
Array
(
[id] => 18879181
[patent_doc_number] => 20240002550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => Process for the treatment of biomass
[patent_app_type] => utility
[patent_app_number] => 18/253431
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253431 | Process for the treatment of biomass | Nov 14, 2021 | Pending |
Array
(
[id] => 17576903
[patent_doc_number] => 20220133758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/524392
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17524392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/524392 | TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS | Nov 10, 2021 | Pending |
Array
(
[id] => 17355352
[patent_doc_number] => 20220016148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => RETINOIC ACID RECEPTOR GAMMA AGONISTS TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/493571
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493571 | RETINOIC ACID RECEPTOR GAMMA AGONISTS TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY | Oct 3, 2021 | Abandoned |
Array
(
[id] => 19586700
[patent_doc_number] => 20240384257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => NUCLEIC ACID EXTRACTION COMPOSITION, NUCLEIC ACID EXTRACTION DEVICE AND NUCLEIC ACID EXTRACTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/578679
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578679 | NUCLEIC ACID EXTRACTION COMPOSITION, NUCLEIC ACID EXTRACTION DEVICE AND NUCLEIC ACID EXTRACTION METHOD | Sep 28, 2021 | Pending |
Array
(
[id] => 18737923
[patent_doc_number] => 20230346825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => CYCLODEXTRIN DERIVATIVES IN THE TREATMENT OR PREVENTION OF LYSOSOMAL NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/029340
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029340 | CYCLODEXTRIN DERIVATIVES IN THE TREATMENT OR PREVENTION OF LYSOSOMAL NEURODEGENERATIVE DISEASES | Sep 28, 2021 | Issued |
Array
(
[id] => 18643311
[patent_doc_number] => 11767371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Hydroxypropyl methyl cellulose acetate succinate, method for producing the same, and composition for hot-melt extrusion
[patent_app_type] => utility
[patent_app_number] => 17/484405
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9397
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484405 | Hydroxypropyl methyl cellulose acetate succinate, method for producing the same, and composition for hot-melt extrusion | Sep 23, 2021 | Issued |
Array
(
[id] => 17627331
[patent_doc_number] => 20220162346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CROSSLINKED COLLOIDAL CELLULOSE NANOCRYSTALS AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/479053
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479053 | Crosslinked colloidal cellulose nanocrystals and methods of preparation and use thereof | Sep 19, 2021 | Issued |
Array
(
[id] => 18815985
[patent_doc_number] => 20230390324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => TREATMENT OF FATTY LIVER DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/246570
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246570 | TREATMENT OF FATTY LIVER DISEASES | Sep 16, 2021 | Abandoned |
Array
(
[id] => 18725919
[patent_doc_number] => 20230340161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => CELLULOSE-CONTAINING MATERIALS
[patent_app_type] => utility
[patent_app_number] => 18/025591
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025591
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025591 | CELLULOSE-CONTAINING MATERIALS | Sep 14, 2021 | Pending |
Array
(
[id] => 18597201
[patent_doc_number] => 20230271995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHODS FOR PRODUCING DIHYDRONICOTINAMIDE RIBOSIDE FROM NICOTINAMIDE RIBOSIDE CHLORIDE
[patent_app_type] => utility
[patent_app_number] => 18/245044
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245044
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245044 | METHODS FOR PRODUCING DIHYDRONICOTINAMIDE RIBOSIDE FROM NICOTINAMIDE RIBOSIDE CHLORIDE | Sep 13, 2021 | Abandoned |
Array
(
[id] => 17443698
[patent_doc_number] => 20220064203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOUND OR SALT THEREOF, AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/462279
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/462279 | Porphyrin compound or salt thereof, cancer therapeutic agent, photosensitizer, and fluorescent probe | Aug 30, 2021 | Issued |